HOME >> BIOLOGY >> NEWS
Dramatic results from combo therapy surprises Krabb-disease researchers

Jan. 9, 2007 -- By all expectations, it shouldn't have worked as well as it did. A combination of bone marrow transplantation and gene therapy greatly lengthened the lives of laboratory mice doomed by a rapidly progressing, fatal neurodegenerative disorder also found in people.

The Washington University School of Medicine in St. Louis researchers who made the discovery set out with low hopes for the combination therapy because on its own, each treatment was only modestly effective for the sick mice.

The mice are called Twitcher mice because the damage that happens in their nervous systems results in twitching. In people, the same genetic defect causes Krabb disease, or globoid-cell leukodystrophy, an inherited disorder that destroys both the brain and the nerves of the body.

"We had everything we needed to test the combination treatment, so we said, 'Let's just give it a try,'" says the study's senior author, Mark Sands, Ph.D., associate professor of medicine and of genetics. "Alone, these therapies resulted in a small survival benefit, but with the combination we were seeing mice with dramatically extended life spans. Ninety-five percent of the Twitcher mice that had the combination treatment were still alive after all the other Twitcher mice had died."

The researchers gave newborn Twitcher mice injections of a gene therapy vector into the brain and infused them with bone marrow from healthy mice. Mice receiving the dual therapy lived more than twice as long (greater than 100 days), on average, as untreated mice or those given a single therapy and had improved motor skills. The research is reported in the January issue of Molecular Therapy.

Although not considered a cure at this stage, the combination therapy offers hope for treatment of diseases like Krabb, which are termed lysosomal storage diseases. These disorders include Niemann-Pick and Tay-Sachs diseases and affect 1 in 5,000 children born each year.

"This may become th
'"/>

Contact: Gwen Ericson
ericsong@wustl.edu
314-286-0141
Washington University School of Medicine
9-Jan-2007


Page: 1 2 3

Related biology news :

1. Dramatic shift from simple to complex marine ecosystems occurred 250M years ago at mass extinction
2. Dramatic rise in number of authors publishing in open access journals, independent survey finds
3. Cooperative science program yields results
4. Delayed treatment of childhood-onset bipolar disorder results in negative outcome in adults
5. Smelling for first time results from knowing abnormalities in congenital loss of smell
6. BDSI announces positive phase III clinical trial results
7. Scientists meet to review Envisat results after 5 years of operations
8. Environment and exercise may affect research results, UA study shows
9. Preliminary results of largest scan of autism DNA information
10. Human trial results show excellent safety data, from Geovaxs DNA/MVA AIDS vaccines
11. Rodent sperm work together for better results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... ... August 18, 2020 , ... ... today announced that the U.S. Food and Drug Administration (FDA) has approved the ... SBI-101, for the treatment of severe COVID-19. Approval of this IND allows Sentien ...
(Date:8/12/2020)... ... , ... Mosio recently announced its newly updated text message-based ... all sizes. With a focus on tracking symptoms and monitoring outbreaks as well ... helps public health departments automate communications and provide more personalized care and resources ...
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, Inc. today ... by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the ... and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to meet surge ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and ... a great surgery is only the beginning of a successful study, while protecting and ... Join Brad Gien, Global Head of Surgery from Envigo in a ...
(Date:7/18/2020)... ... , ... dicentra , a leading Contract Research Organization ... pleased to announce that Charles Galea has joined its clinical trials division as ... accomplished and results-driven sales executive with over 10 years of expertise in business ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research using ... suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. ... has been using the zebrafish model to investigate the causes of leukaemia and ...
(Date:7/7/2020)... (PRWEB) , ... July 06, 2020 , ... ... Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, ... 2003, Bio-IT World has hosted an elite awards program, highlighting outstanding examples of ...
Breaking Biology Technology:
Cached News: